Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.4B |
| 2 |
Amazon
AMZN
|
+$2.49B |
| 3 |
NVIDIA
NVDA
|
+$2.18B |
| 4 |
Microsoft
MSFT
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.21B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$1.75B |
| 2 |
Broadcom
AVGO
|
+$1.56B |
| 3 |
Dell
DELL
|
+$1.09B |
| 4 |
SNDK
Sandisk
SNDK
|
+$899M |
| 5 |
T-Mobile US
TMUS
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.39% |
| 2 | Technology | 3.64% |
| 3 | Industrials | 1.09% |
| 4 | Consumer Discretionary | 0.89% |
| 5 | Financials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11101
Cardio Diagnostics
CDIO
$5.92M
| $26.1K | ﹤0.01% |
11,933
-69,350
| -85% | -$131K |
|
|
CYCU
11102
Cycurion Inc
CYCU
$88.4M
| $26.1K | ﹤0.01% |
5,638
+3,871
| +219% | +$28.2K |
|
|
LGO
11103
CALL
Largo
LGO
$71.1M
| $25.7K | ﹤0.01% |
41,500
+25,000
| +152% | +$25.8K |
|
11104
Wearable Devices
WLDS
$3.89M
| $25.6K | ﹤0.01% |
15,496
+11,411
| +279% | +$34.5K |
|
|
RPGL
11105
Republic Power Group Ltd
RPGL
$23.3M
| $25.5K | ﹤0.01% |
+12,958
| New | +$255K |
|
11106
Processa Pharmaceuticals
PCSA
$5.48M
| $25.5K | ﹤0.01% |
+13,264
| New | +$34.3K |
|
11107
Westwater Resources
WWR
$69.6M
| $25.4K | ﹤0.01% |
50,275
-636,397
| -93% | -$377K |
|
11108
CALL
Black Diamond Therapeutics
BDTX
$113M
| $25.2K | ﹤0.01% |
13,600
-4,700
| -26% | -$11.5K |
|
|
SLGB
11109
Smart Logistics Global
SLGB
$14.3M
| $25.1K | ﹤0.01% |
+40,152
| New | +$26.9K |
|
11110
Beamr Imaging
BMR
$19.3M
| $25K | ﹤0.01% |
+17,878
| New | +$31.3K |
|
11111
Marker Therapeutics
MRKR
$19.5M
| $24.7K | ﹤0.01% |
16,832
-19,471
| -54% | -$28.4K |
|
11112
Envoy Medical
COCH
$55M
| $24.7K | ﹤0.01% |
+31,223
| New | +$21.2K |
|
11113
PUT
Pacific Biosciences
PACB
$417M
| $24.7K | ﹤0.01% |
14,700
-35,700
| -71% | -$51.9K |
|
|
MVO
11114
CALL
DELISTED
MV Oil Trust
MVO
| $24.6K | ﹤0.01% |
13,900
+1,900
| +16% | +$3.96K |
|
|
VENU
11115
PUT
Venu Holding Corp
VENU
$96.7M
| $24.5K | ﹤0.01% |
+10,800
| New | +$38.6K |
|
11116
Codere Online Luxembourg Warrants
CDROW
| $24.5K | ﹤0.01% |
25,003
+37
| +0.1% | +$29 |
|
11117
BuzzFeed
BZFD
$87.5M
| $24.4K | ﹤0.01% |
16,741
-59,188
| -78% | -$68K |
|
11118
Acurx Pharmaceuticals
ACXP
$5.8M
| $24.4K | ﹤0.01% |
15,727
-38,915
| -71% | -$81K |
|
|
ORKT
11119
Orangekloud Technology Inc
ORKT
$6.01M
| $24.2K | ﹤0.01% |
+23,708
| New | +$26.3K |
|
|
NMG
11120
PUT
Nouveau Monde Graphite
NMG
$444M
| $24K | ﹤0.01% |
+16,000
| New | +$30.2K |
|
|
SDEV
11121
Stablecoin Development Corp
SDEV
$43.4M
| $23.8K | ﹤0.01% |
22,639
-98,465
| -81% | -$136K |
|
|
USBC
11122
USBC Inc
USBC
$173M
| $23.5K | ﹤0.01% |
75,226
+58,210
| +342% | +$22.1K |
|
11123
PUT
8x8 Inc
EGHT
$264M
| $23.4K | ﹤0.01% |
+13,700
| New | +$27.6K |
|
11124
PUT
Aldeyra Therapeutics
ALDX
$82.6M
| $23.2K | ﹤0.01% |
10,900
-54,900
| -83% | -$94.4K |
|
11125
PharmaCyte Biotech
PMCB
$4.1M
| $23.1K | ﹤0.01% |
30,064
+18,534
| +161% | +$14K |
|
Similar funds
Jane Street's Q2 2026 Portfolio in Review
As of Q2 2026, Jane Street held 13,869 positions worth $1.21T, up 55% from $777B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jane Street deployed $44.4B of net new capital in Q2 2026, opening 2,565 new positions and adding to 4,995 existing holdings. Its largest new stake was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Marvell Technology, an estimated $1.75B trimmed.
- Jane Street's largest Q2 2026 buy was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $17.4B increase.
- Jane Street's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.75B.
- Jane Street fully exited iShares Core US Aggregate Bond ETF in Q2 2026, selling an estimated $239M.
- Jane Street's ten largest holdings make up 32% of its $1.21T portfolio in Q2 2026.
- Jane Street opened 2,565 new positions and closed 2,484 in Q2 2026.
- Jane Street's portfolio value rose 55% quarter-over-quarter to $1.21T.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.